loadpatents
Patent applications and USPTO patent grants for Kass; David A..The latest application filed is for "engineered tuberous sclerosis complex 2 polypeptides".
Patent | Date |
---|---|
Engineered Tuberous Sclerosis Complex 2 Polypeptides App 20220118017 - Kass; David A. ;   et al. | 2022-04-21 |
Engineered Tsc2 App 20200149062 - Kass; David A. ;   et al. | 2020-05-14 |
Nitroxyl Progenitors In The Treatment Of Heart Failure App 20160228460 - Wink; David A. ;   et al. | 2016-08-11 |
Thiol-Sensitive Positive Inotropes App 20160166604 - Paolocci; Nazareno ;   et al. | 2016-06-16 |
Nitroxyl Progenitors In The Treatment Of Heart Failure App 20150004259 - Wink; David A. ;   et al. | 2015-01-01 |
Method of treating ischemia/reperfusion injury with nitroxyl donors Grant 8,268,890 - Wink , et al. September 18, 2 | 2012-09-18 |
Nitroxyl Progenitors in the Treatment of Heart Failure App 20120201907 - WINK; David A. ;   et al. | 2012-08-09 |
Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure App 20110263668 - Barouch; Lili Ayala ;   et al. | 2011-10-27 |
Nitroxyl Progenitors in the Treatment of Heart Failure App 20110081427 - Wink; David A. ;   et al. | 2011-04-07 |
Nitroxyl progenitors in the treatment of heart failure Grant 7,863,262 - Wink , et al. January 4, 2 | 2011-01-04 |
Thiol-Sensitive Positive Inotropes App 20090298795 - Paolocci; Nazareno ;   et al. | 2009-12-03 |
Method Of Treating Ischemia/reperfusion Injury With Nitroxyl Donors App 20090246296 - Wink; David A. ;   et al. | 2009-10-01 |
Nitroxyl progenitors in the treatment of heart failure App 20050192254 - Wink, David A. ;   et al. | 2005-09-01 |
Nitroxyl progenitors in the treatment of heart failure Grant 6,936,639 - Wink , et al. August 30, 2 | 2005-08-30 |
Method of treating ischemia/reperfusion injury with nitroxyl donors App 20040038947 - Wink, David A. ;   et al. | 2004-02-26 |
Nitroxyl progenitors in the treatment of heart failure App 20040039063 - Wink, David A. ;   et al. | 2004-02-26 |
Assessing cardiac contractility and cardiovascular interaction Grant 6,090,047 - Kass , et al. July 18, 2 | 2000-07-18 |
NCAGE Code | 78H89 | KASS, DAVID A |
NCAGE Code | 4RRZ6 | KASS DAVID A |
CAGE Code | 4RRZ6 | KASS, DAVID A |
CAGE Code | 78H89 | KASS, DAVID A |
S.A.M. Registration | 78H89 [79551767] | KASS, DAVID A |
DUNS | 079551767 | Kass, David A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.